person · Reporting owner
Ladiwala Shiraz Shabanali
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | September 09, 2026 | September 11, 2026 |
| Patheon N.V.PTHN · Entity 173467 | Director | August 29, 2017 | August 29, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date September 09, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units - 7SEC Table II · derivative / convertible security | Direct | 2,510 |
Reported balance
After 2026-09-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 2,510 · Balance 2,510 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2: RSUs that vest on September 9, 2027 F3: Not Applicable |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest on September 9, 2027
F3: Not Applicable
Patheon N.V.
Report date August 29, 2017 · Filed August 29, 2017
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 11, 2026 18:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 7 · Derivative | 2,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000096 · primary_doc.xml · derivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,510 Underlying: Common Stock · 2,510 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 9, 2027 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2026 Filed Aug 17, 2026 21:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 6 · Derivative | 3,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000089 · primary_doc.xml · derivative · entry 2 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on August 15, 2026 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2026 Filed Aug 17, 2026 21:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 3,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000089 · primary_doc.xml · nonDerivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2026 Filed Mar 10, 2026 21:43 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | PurchaseCommon Stock | 3,500 | $72.23 | $252,805.00 |
DisclosureSEC source: 0000724004-26-000023 · primary_doc.xml · nonDerivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,523 Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 6 · Derivative | 3,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000008 · primary_doc.xml · derivative · entry 3 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,810 Underlying: Common Stock · 3,810 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vest on August 15, 2026 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 5 · Derivative | 1,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000008 · primary_doc.xml · derivative · entry 2 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,949 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on August 15, 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000008 · primary_doc.xml · nonDerivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2024 Filed Sep 6, 2024 15:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 4 · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000022 · primary_doc.xml · derivative · entry 2 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on September 1, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2024 Filed Sep 6, 2024 15:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000022 · primary_doc.xml · nonDerivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 16:08 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 5 · Derivative | 1,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000019 · primary_doc.xml · derivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,949 Underlying: Common Stock · 1,949 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:36 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 4 · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000035 · primary_doc.xml · derivative · entry 2 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 1, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 19:45 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000025 · primary_doc.xml · derivative · entry 2 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 19:45 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000025 · primary_doc.xml · nonDerivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2023 Filed Sep 6, 2023 16:36 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 3 · Derivative | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000035 · primary_doc.xml · derivative · entry 3 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vested on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Sep 6, 2023 16:36 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000035 · primary_doc.xml · nonDerivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Dec 14, 2022 16:26 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 3 · Derivative | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000045 · primary_doc.xml · derivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40 Underlying: Common Stock · 40 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs granted in lieu of cash compensation for Board Services that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:12 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000024 · primary_doc.xml · derivative · entry 2 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on August 15, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:12 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000024 · primary_doc.xml · nonDerivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 18, 2022 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 2 · Derivative | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000031 · primary_doc.xml · derivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055 Underlying: Common Stock · 1,055 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2021 Filed Nov 19, 2021 17:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 1 · Derivative | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027137 · rdgdoc.xml · derivative · entry 1 Ladiwala Shiraz Shabanali · CIK 0001715573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 405 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuers commo stock F2 · kind: Represents 282 RSUs related to a pro-rated annual grant and 123 RSUs granted for the conversion of cash compensation for Board of Directors services for the next 9 months F3 · derivative.exercise_date: RSUs that vest August 15, 2022 F4 · derivative.expiration_date: Not applicable Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.